ArticleTargeted oncology2024

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Abdulazeez Salawu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.